ARCT logo

ARCT Arcturus Therapeutics Holdings Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$8.82
-0.49 (-5.30%)

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung d…

Market Cap: $254.11Marcturusrx.com

Price

No data yet.

Social Signal Score

60
5d
—
30d
60
2 mentions
—
60d
60
4 mentions
—
90d
60
7 mentions
—
news: 7

Analyst Ratings

21 analysts
Buyconsensus
Strong Buy 0Buy 12Hold 5Sell 4Strong Sell 0
Avg price target$30.5+245.9%
Low $20Median $30.5High $41
Current Consensus

Revenue

$18.30M
$0.00$53.43M$106.86M$160.29M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.06
$-2.29–$-1.71
7 analysts
FY2026
$-3.02
$-3.53–$-2.67
5 analysts
FY2027
$-3.55
$-3.87–$-3.08
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Joseph E. Payne
Sector
Healthcare
Industry
Biotechnology
Employees
109
Beta
2.60
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-0.65
arcturusrx.com